Viva Biotech Holdings
VBIZF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$402.68M
Close$
$-0.00
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $402.68 Million |
|---|---|
| Enterprise Value | $296.32 Million |
| Earnings per Share | $0.1 |
| Beta | 1.38 |
| Outstanding Shares | 2,104,969,000 |
Return
| Return on Equity | 8.80% |
|---|---|
| Return on Assets | 5.06% |
| Return on Invested Capital | 7.29% |
Valuation & Multiples
| P/E Ratio | 12.89 |
|---|---|
| PEG | -37.63 |
| Price to Sales | 0.19 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 0.71 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.03 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Viva Biotech Holdings
2,213 employees
CEO: Chen Cheney Mao
Viva Biotech Holdings, founded in 2008 and based in Shanghai, China, operates as an investment holding company primarily dedicated to providing comprehensive, structure-based drug discovery services to biotechnology and pharmaceutical cl...